As of 2025-07-08, the Relative Valuation of Rapt Therapeutics Inc (RAPT) is (80.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.16 USD, the upside of Rapt Therapeutics Inc based on Relative Valuation is -1092.4%.
The range of the Relative Valuation is (62.07) - (113.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 18.4x | 12.9x |
| Forward P/E multiples | 10.1x - 20.9x | 13.4x |
| Fair Price | (62.07) - (113.19) | (80.98) |
| Upside | -860.7% - -1487.1% | -1092.4% |
| Date | P/E |
| 2025-07-03 | -1.31 |
| 2025-07-02 | -1.30 |
| 2025-07-01 | -1.19 |
| 2025-06-30 | -1.30 |
| 2025-06-27 | -1.37 |
| 2025-06-26 | -1.58 |
| 2025-06-25 | -1.55 |
| 2025-06-24 | -1.33 |
| 2025-06-23 | -1.21 |
| 2025-06-20 | -1.21 |
| 2025-06-18 | -1.20 |
| 2025-06-17 | -1.27 |
| 2025-06-16 | -1.34 |
| 2025-06-13 | -1.35 |
| 2025-06-12 | -1.42 |
| 2025-06-11 | -1.43 |
| 2025-06-10 | -1.55 |
| 2025-06-09 | -1.56 |
| 2025-06-06 | -1.52 |
| 2025-06-05 | -1.33 |
| 2025-06-04 | -1.33 |
| 2025-06-03 | -1.28 |
| 2025-06-02 | -1.22 |
| 2025-05-30 | -1.15 |
| 2025-05-29 | -1.21 |
| 2025-05-28 | -1.26 |
| 2025-05-27 | -1.27 |
| 2025-05-23 | -1.60 |
| 2025-05-22 | -1.11 |
| 2025-05-21 | -1.15 |
| 2025-05-20 | -1.25 |
| 2025-05-19 | -1.26 |
| 2025-05-16 | -1.09 |
| 2025-05-15 | -1.05 |
| 2025-05-14 | -0.97 |
| 2025-05-13 | -0.97 |
| 2025-05-12 | -1.14 |
| 2025-05-09 | -0.98 |
| 2025-05-08 | -1.04 |
| 2025-05-07 | -1.04 |
| 2025-05-06 | -1.05 |
| 2025-05-05 | -1.19 |
| 2025-05-02 | -1.26 |
| 2025-05-01 | -1.19 |
| 2025-04-30 | -1.20 |
| 2025-04-29 | -1.18 |
| 2025-04-28 | -1.20 |
| 2025-04-25 | -1.14 |
| 2025-04-24 | -1.14 |
| 2025-04-23 | -1.12 |